Mansoura University Hospital
Al Mansurah, Egypt
NCT Number: NCT00738855
Mini abstract :
Altogether 100 patients with 117 episodes of ASBO were randomized into control and gastrografin groups. Eight episodes in eight patients were excluded. Gastrografin group showed a significant decrease of both the time between admission and operation and that of hospital stay .The need for surgery was reduced but statistically insignificant.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Al Mansurah, Egypt
Abstract
Background:
Many published studies have shown that Gastrografin can be used for diagnosis post operative acute small bowel obstruction (ASBO) and assessing the need for surgical intervention .However,the studies have reported conflicting results hence the aim of our study to test this hypothesis.
Patients and methods :
Altogether 100 patients with 117 episodes of ASBO were randomized into control and gastrografin groups in a double blinded fashion. Eight episodes in eight patients were excluded due to protocol violation. In Gastrografin group,100 ml of the dye administered through a nasogastric tube and complete obstruction has been considered if the contrast failed to reach the colon on the 24-hour film. Patients were operated on only if they developed signs of strangulation or failed to improve within 48 hours.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
100 ml of the dye administered through a nasogastric tube
Other names: oral contrast
A nasogastric tube
Other names: no oral contrast
Time frame: 48 hours
Time frame: 48 hours
Mansoura University
Other
Clinical Impacts of Oral Gastrografin Follow Through in Adhesive Small Bowel Obstruction (SBO).
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01068340
Cicatrix, Digestive System Diseases
Los Angeles, California, United States
View Trial DetailsNCT07150390
Small Bowel Obstruction, Small Bowel Obstruction Adhesion
Nanjing, Jiangsu, China
View Trial DetailsNCT05842135
Small Bowel Obstruction
Pesaro, Pesaro-Urbino, Italy
View Trial DetailsNCT05843097
Disease, Pathologic Processes
Seville, Andalusia, Spain
View Trial Details